Foghorn Therapeutics (FHTX) Earnings Date & Reports

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

FHTX is expected to report earnings to fall 15.86% to -24 cents per share on November 10

Foghorn Therapeutics FHTX Stock Earnings Reports

Q3'26

Est.

$-0.24

Q1'26

Missed

by $0.01

Q4'25

Missed

by $0.10

Q3'25

Beat

by $0.08

Q2'25

Beat

by $0.07

The last earnings report on May 07 showed earnings per share of -28 cents, missing the estimate of -28 cents. With 95.55K shares outstanding, the current market capitalization sits at 277.33M.

View a ticker or compare two or three

FHTX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for FHTX